EPISODE · Nov 14, 2023 · 9 MIN
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
from Science, Spoken · host WIRED
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
No transcript for this episode yet
Similar Episodes
No similar episodes found.